Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma (GBM)
Head and Neck Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Esophageal Cancer

Interventions

DIAGNOSTIC_TEST: PET/CT （[18F]AlF-NOTA-PCP2）
DIAGNOSTIC_TEST: [18F]AlF-NOTA-PCP2 PET/CT Imaging for PD-L1 Expression in Malignant Tumors

Sponsor

Man Hu